Checked
Class IIDrug recallOngoing
Amlodipine and Olmesartan Medoxomil Tablets recall
Recalled by Ascend Laboratories, LLC of Bedminster, NJ · FDA report 07/29/2026
Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.
- Class
- Class II
- Moderate
- Status
- Ongoing
- Recall started
- 07/08/2026
- Distribution
- Nationwide
Reason for recall
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Recalled product
- Product
- Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30
- Lot and code info
- Lot 25121311, expiry 3/31/2028
- Quantity
- 6,192 bottles
- Brand names
- AMLODIPINE AND OLMESARTAN MEDOXOMIL
- Recall number
- D-0712-2026
- Event ID
- 99385
- Initiated by
- Voluntary: Firm initiated
Where it was distributed
Nationwide in the USA
- Nationwide
Recall timeline
- 07/08/2026Firm started the recall
- 07/20/2026FDA classified it as Class II
- 07/29/2026Published in the FDA enforcement report
More recalls from Ascend Laboratories
- Class IIIDrugOngoing08/05/2026Dabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx only...Ascend Laboratories, LLC · 3 products · Failed impurity/degradation specification: an OOS result observed...
- Class IIIDrugOngoing07/29/2026Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10), Rx Only, Manufactured by: Alkem...Ascend Laboratories, LLC · 2 products · Failed Impurities/Degradation Specifications: OOS result was...
- Class IIDrugOngoing06/17/2026Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured...Ascend Laboratories, LLC · Failed Dissolution Specifications: An out-of-specification (OOS)...
- Class IIDrugOngoing06/10/2026Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem...Ascend Laboratories, LLC · Failed Dissolution Specifications: Olmesartan Medoxomil content...
- Class IIDrugOngoing05/20/2026Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured...Ascend Laboratories, LLC · Failed Dissolution Specifications
- Class IIDrugOngoing10/22/2025Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count...Ascend Laboratories, LLC · 4 products · Failed Dissolution Specifications
Frequently asked questions
- Why was Amlodipine and Olmesartan Medoxomil Tablets recalled?
- Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
- What does Class II mean?
- Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
- Where was the recalled product sold?
- Nationwide in the USA
- Is this recall still active?
- The FDA lists the recall as ongoing. The recall is still in progress.
Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 07/29/2026 · Do not rely on openFDA to make decisions regarding medical care